• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合多组学与进化计算以识别复杂疾病早期诊断和治疗的分子及模块生物标志物。

Multiomics with Evolutionary Computation to Identify Molecular and Module Biomarkers for Early Diagnosis and Treatment of Complex Disease.

作者信息

Cheng Han, Liang Mengyu, Gao Yiwen, Zhao Wenshan, Guo Wei-Feng

机构信息

School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.

School of Electrical and Information Engineering, Zhengzhou University, Zhengzhou 450001, China.

出版信息

Genes (Basel). 2025 Feb 20;16(3):244. doi: 10.3390/genes16030244.

DOI:10.3390/genes16030244
PMID:40149396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11942451/
Abstract

It is important to identify disease biomarkers (DBs) for early diagnosis and treatment of complex diseases in personalized medicine. However, existing methods integrating intelligence technologies and multiomics to predict key biomarkers are limited by the complex dynamic characteristics of omics data, making it difficult to meet the high-precision requirements for biomarker characterization in large dimensions. This study reviewed current analysis methods of evolutionary computation (EC) by considering the essential characteristics of DB identification problems and the advantages of EC, aiming to explore the complex dynamic characteristics of multiomics. In this study, EC-based biomarker identification strategies were summarized as evolutionary algorithms, swarm intelligence and other EC methods for molecular and module DB identification, respectively. Finally, we pointed out the challenges in current research and future research directions. This study can enrich the application of EC theory and promote interdisciplinary integration between EC and bioinformatics.

摘要

在个性化医疗中,识别疾病生物标志物(DBs)对于复杂疾病的早期诊断和治疗至关重要。然而,现有的将智能技术与多组学相结合以预测关键生物标志物的方法受到组学数据复杂动态特征的限制,难以满足大维度生物标志物表征的高精度要求。本研究通过考虑DB识别问题的本质特征和进化计算(EC)的优势,回顾了当前的进化计算分析方法,旨在探索多组学的复杂动态特征。在本研究中,基于EC的生物标志物识别策略分别总结为用于分子和模块DB识别的进化算法、群体智能及其他EC方法。最后,我们指出了当前研究中的挑战和未来的研究方向。本研究可以丰富EC理论的应用,并促进EC与生物信息学之间的跨学科整合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effb/11942451/9e616f0b96ea/genes-16-00244-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effb/11942451/046e37642ab9/genes-16-00244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effb/11942451/fad2d70764dd/genes-16-00244-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effb/11942451/9e616f0b96ea/genes-16-00244-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effb/11942451/046e37642ab9/genes-16-00244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effb/11942451/fad2d70764dd/genes-16-00244-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effb/11942451/9e616f0b96ea/genes-16-00244-g003.jpg

相似文献

1
Multiomics with Evolutionary Computation to Identify Molecular and Module Biomarkers for Early Diagnosis and Treatment of Complex Disease.结合多组学与进化计算以识别复杂疾病早期诊断和治疗的分子及模块生物标志物。
Genes (Basel). 2025 Feb 20;16(3):244. doi: 10.3390/genes16030244.
2
Multi-omics approaches for biomarker discovery and precision diagnosis of prediabetes.用于糖尿病前期生物标志物发现和精准诊断的多组学方法。
Front Endocrinol (Lausanne). 2025 Mar 14;16:1520436. doi: 10.3389/fendo.2025.1520436. eCollection 2025.
3
Precision Reimagined: CRISPR and Multiomics Transform Systemic Lupus Erythematosus Diagnosis and Therapy.重新构想的精准医学:CRISPR与多组学改变系统性红斑狼疮的诊断与治疗
Int J Rheum Dis. 2025 Apr;28(4):e70189. doi: 10.1111/1756-185X.70189.
4
Multiomics, artificial intelligence, and precision medicine in perinatology.围产学中的多组学、人工智能和精准医学。
Pediatr Res. 2023 Jan;93(2):308-315. doi: 10.1038/s41390-022-02181-x. Epub 2022 Jul 8.
5
Leveraging Multi-Omics Approaches and Advanced Technologies to Unravel the Molecular Complexities, Modifiers, and Precision Medicine Strategies for Hemoglobin H Disease.利用多组学方法和先进技术揭示血红蛋白 H 病的分子复杂性、修饰因子和精准医疗策略。
Eur J Haematol. 2024 Dec;113(6):738-744. doi: 10.1111/ejh.14319. Epub 2024 Oct 9.
6
MORE: a multi-omics data-driven hypergraph integration network for biomedical data classification and biomarker identification.MORE:一种用于生物医学数据分类和生物标志物识别的多组学数据驱动的超图整合网络。
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbae658.
7
Multiomics Network Medicine Approaches to Precision Medicine and Therapeutics in Cardiovascular Diseases.多组学网络医学在心血管疾病精准医学和治疗中的应用。
Arterioscler Thromb Vasc Biol. 2023 Apr;43(4):493-503. doi: 10.1161/ATVBAHA.122.318731. Epub 2023 Feb 16.
8
Phenomics and Robust Multiomics Data for Cardiovascular Disease Subtyping.表型组学和稳健的多组学数据在心血管疾病亚型分类中的应用。
Arterioscler Thromb Vasc Biol. 2023 Jul;43(7):1111-1123. doi: 10.1161/ATVBAHA.122.318892. Epub 2023 May 25.
9
Twin Scholarships of Glycomedicine and Precision Medicine in Times of Single-Cell Multiomics.单细胞多组学时代的糖药物学和精准医学双料奖学金
OMICS. 2024 Jul;28(7):319-323. doi: 10.1089/omi.2024.0111. Epub 2024 Jun 6.
10
Perspective: Multiomics and Artificial Intelligence for Personalized Nutritional Management of Diabetes in Patients Undergoing Peritoneal Dialysis.视角:多组学与人工智能在腹膜透析患者糖尿病个性化营养管理中的应用
Adv Nutr. 2025 Mar;16(3):100378. doi: 10.1016/j.advnut.2025.100378. Epub 2025 Jan 20.

本文引用的文献

1
Multimodal multiobjective optimization with structural network control principles to optimize personalized drug targets for drug discovery of individual patients.基于结构网络控制原理的多模态多目标优化,以优化个体患者药物研发的个性化药物靶点。
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbaf007.
2
GD-Net: An Integrated Multimodal Information Model Based on Deep Learning for Cancer Outcome Prediction and Informative Feature Selection.GD-Net:一种基于深度学习的集成多模态信息模型,用于癌症预后预测和信息性特征选择。
J Cell Mol Med. 2024 Dec;28(23):e70221. doi: 10.1111/jcmm.70221.
3
Reconstructing Molecular Networks by Causal Diffusion Do-Calculus Analysis with Deep Learning.
通过深度学习的因果扩散干预演算分析重建分子网络
Adv Sci (Weinh). 2024 Dec;11(46):e2409170. doi: 10.1002/advs.202409170. Epub 2024 Oct 23.
4
Single-cell CAR T atlas reveals type 2 function in 8-year leukaemia remission.单细胞 CAR T 图谱揭示 8 年白血病缓解中的 2 型功能。
Nature. 2024 Oct;634(8034):702-711. doi: 10.1038/s41586-024-07762-w. Epub 2024 Sep 25.
5
Network topology and interaction logic determine states it supports.网络拓扑结构和交互逻辑决定了它所支持的状态。
NPJ Syst Biol Appl. 2024 Aug 28;10(1):98. doi: 10.1038/s41540-024-00423-8.
6
Constrained Multi-objective Optimization-Based Temporal Network Observability for Biomarker Identification of Individual Patients.基于约束多目标优化的个体患者生物标志物识别时间网络可观测性
IEEE J Biomed Health Inform. 2024 Jul 30;PP. doi: 10.1109/JBHI.2024.3435418.
7
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma.基于临床-组织学-基因组分析的多分类器系统预测肾乳头状细胞癌复发。
Nat Commun. 2024 Jul 23;15(1):6215. doi: 10.1038/s41467-024-50369-y.
8
Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression.单细胞和批量转录组学的综合分析开发了一种稳健的神经内分泌细胞内在特征,以预测前列腺癌的进展。
Theranostics. 2024 Jan 1;14(3):1065-1080. doi: 10.7150/thno.92336. eCollection 2024.
9
Deciphering driver regulators of cell fate decisions from single-cell transcriptomics data with CEFCON.利用 CEFCON 从单细胞转录组学数据中破译细胞命运决策的驱动调控因子。
Nat Commun. 2023 Dec 20;14(1):8459. doi: 10.1038/s41467-023-44103-3.
10
DGIdb 5.0: rebuilding the drug-gene interaction database for precision medicine and drug discovery platforms.DGIdb 5.0:为精准医学和药物发现平台重建药物-基因相互作用数据库。
Nucleic Acids Res. 2024 Jan 5;52(D1):D1227-D1235. doi: 10.1093/nar/gkad1040.